• 1
    Hypertension in the Asia Pacific region – the problem and the solution. APSH web site. Available at: Accessed April 3, 2012.
  • 2
    Chiang CE, Chen CH. Hypertension in the Asia-Pacific region. J Hum Hypertens 2008;22: 441443.
  • 3
    Ma WJ, Tang JL, Zhang YH, et al. Hypertension prevalence, awareness, treatment, control, and associated factors in adults in southern china. Am J Hypertens 2012;25: 590596.
  • 4
    KNHANES. Korean National Health and Nutrition Examination Survey web site. Available at: Accessed March 19, 2012.
  • 5
    Zhang XF, Attia J, D'Este C, Ma XY. The relationship between higher blood pressure and ischaemic, haemorrhagic stroke among Chinese and Caucasians: meta-analysis. Eur J Cardiovasc Prev Rehabil 2006;13: 429437.
  • 6
    Kengne AP, Patel A, Barzi F, et al. Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. J Hypertens 2007;25: 12051213.
  • 7
    Martiniuk AL, Lee CM, Lawes CM, et al. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region. J Hypertens 2007;25: 7379.
  • 8
    Woodward M, Tsukinoki-Murakami R, Murakami Y, et al. The epidemiology of stroke amongst women in the Asia-Pacific region. Womens Health (Lond Engl) 2011;7: 305317.
  • 9
    Mancia G, De BG, Dominiczak A, et al. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25: 11051187.
  • 10
    Mancia G, Parati G, Bilo G, Choi J, Kilama MO, Ruilope LM. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study. J Hypertens 2011;29: 600609.
  • 11
    Hasebe N, Kikuchi K. Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study. J Hypertens 2005;23: 445453.
  • 12
    European Medicines Agency. Guideline on clinical investigation of medicinal products in the treatment of hypertension. London: EMA, 2010. EMA/238/1995/Rev. 3.
  • 13
    Huang J, Sun NL, Hao YM, et al. Efficacy and tolerability of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients not adequately controlled with valsartan monotherapy. Clin Exp Hypertens 2011;33: 179186.
  • 14
    Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009;27: 21212158.
  • 15
    Julius S, Kjeldsen SE, Brunner H, et al. VALUE trial: long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk. Am J Hypertens 2003;16: 544548.
  • 16
    Weber MA, Julius S, Kjeldsen SE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 2004;363: 20492051.
  • 17
    National Institute for Health and Clinical Excellence (NICE). Guideline CG127. Hypertension: Clinical management of primary hypertension in adults. NICE web site. Available at: Accessed April 20, 2012.